Create Alert
Watchlist

Aarti Pharmalabs Ltd.

₹721.55
-1.90 (0.26%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
724.00
Prev. Close
723.45
Volume
1,43,818
Total traded value
10.38 Cr
Upper Circuit
865.85
Lower Circuit
577.25

Fundamentals

Market Cap₹6,545Cr
ROE11.72%
P/E Ratio(TTM)27.30
EPS(TTM)26.45
P/B Ratio3.20
Dividend Yield0.69%
Industry P/E33.40
Book Value225.73
Debt to Equity0.32
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aarti Pharmalabs

Aarti Pharmalabs Limited is a leading global manufacturer of pharmaceutical products, including Active Pharmaceutical Ingredients and Xanthine Derivatives, based in India. Its primary vision is to establish itself as a 'global partner of choice' for major consumers of both Pharmaceutical and Nutraceutical products. The company's objective is to speed up innovation and provide high-quality pharmaceutical solutions that improve healthcare through advanced chemistry. It specializes in developing and manufacturing Highly Potent APIs (HPAPIs), which are critical for drugs used in oncology, corticosteroids, and cytotoxic medicines. A key strength is its strategic backward integration for most APIs it produces, which provides better control over the entire production value chain. The company has an extensive global footprint, exporting its products to key regulated markets like the United States, the European Union, and Japan.;
Parent OrganisationAarti Pharmalabs
Managing DirectorSmt. Hetal Gogri Gala, Shri Narendra J. Salvi
Founded2019
NSE SymbolAARTIPHARM

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
42.88%
Retail And Others
42.14%
Foreign Institutions
8.02%
Other Domestic Institutions
6.17%
Mutual Funds
0.79%

Top Mutual Funds Invested(2)

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.77
Emcure Pharmaceuticals
NA
(0.00%)
32.27
Wockhardt
NA
(0.00%)
-433.15
Cohance Lifesciences
NA
(0.00%)
66.20